nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLCO4C1—Methotrexate—psoriasis	0.0661	0.0839	CbGbCtD
Levothyroxine—SLCO1B3—Mycophenolate mofetil—psoriasis	0.0646	0.082	CbGbCtD
Levothyroxine—SLCO1C1—Methotrexate—psoriasis	0.0464	0.0589	CbGbCtD
Levothyroxine—ALB—Acitretin—psoriasis	0.044	0.0559	CbGbCtD
Levothyroxine—CYP2C8—Tazarotene—psoriasis	0.043	0.0546	CbGbCtD
Levothyroxine—SLCO1B1—Mycophenolate mofetil—psoriasis	0.0376	0.0478	CbGbCtD
Levothyroxine—SLCO1A2—Prednisolone—psoriasis	0.0338	0.0429	CbGbCtD
Levothyroxine—SLCO1A2—Hydrocortisone—psoriasis	0.032	0.0406	CbGbCtD
Levothyroxine—SLCO1A2—Prednisone—psoriasis	0.0319	0.0405	CbGbCtD
Levothyroxine—SLCO1A2—Cyclosporine—psoriasis	0.0302	0.0384	CbGbCtD
Levothyroxine—SLCO1B1—Cyclosporine—psoriasis	0.0285	0.0362	CbGbCtD
Levothyroxine—SLCO1B3—Methotrexate—psoriasis	0.0259	0.0329	CbGbCtD
Levothyroxine—ALB—Mycophenolate mofetil—psoriasis	0.0206	0.0262	CbGbCtD
Levothyroxine—SLCO1A2—Dexamethasone—psoriasis	0.0199	0.0253	CbGbCtD
Levothyroxine—CYP2C8—Cholecalciferol—psoriasis	0.0184	0.0233	CbGbCtD
Levothyroxine—ALB—Prednisone—psoriasis	0.0165	0.0209	CbGbCtD
Levothyroxine—SLCO1A2—Methotrexate—psoriasis	0.016	0.0203	CbGbCtD
Levothyroxine—CYP2C8—Mycophenolate mofetil—psoriasis	0.0159	0.0202	CbGbCtD
Levothyroxine—SLCO1B1—Methotrexate—psoriasis	0.0151	0.0192	CbGbCtD
Levothyroxine—CYP3A4—Calcitriol—psoriasis	0.0145	0.0184	CbGbCtD
Levothyroxine—CYP2C8—Hydrocortisone—psoriasis	0.0128	0.0162	CbGbCtD
Levothyroxine—SERPINA7—vertebral column—psoriasis	0.0122	0.557	CbGeAlD
Levothyroxine—CYP2C8—Cyclosporine—psoriasis	0.0121	0.0153	CbGbCtD
Levothyroxine—CYP3A4—Methoxsalen—psoriasis	0.0112	0.0143	CbGbCtD
Levothyroxine—ABCB1—Mycophenolate mofetil—psoriasis	0.0108	0.0137	CbGbCtD
Levothyroxine—ABCB1—Betamethasone—psoriasis	0.00925	0.0117	CbGbCtD
Levothyroxine—ABCB1—Prednisolone—psoriasis	0.00912	0.0116	CbGbCtD
Levothyroxine—ABCB1—Hydrocortisone—psoriasis	0.00865	0.011	CbGbCtD
Levothyroxine—ABCB1—Prednisone—psoriasis	0.00862	0.0109	CbGbCtD
Levothyroxine—ALB—Methotrexate—psoriasis	0.00826	0.0105	CbGbCtD
Levothyroxine—ABCB1—Cyclosporine—psoriasis	0.00817	0.0104	CbGbCtD
Levothyroxine—CYP2C8—Dexamethasone—psoriasis	0.00795	0.0101	CbGbCtD
Levothyroxine—CYP3A4—Cholecalciferol—psoriasis	0.00745	0.00946	CbGbCtD
Levothyroxine—CYP3A4—Mycophenolate mofetil—psoriasis	0.00646	0.0082	CbGbCtD
Levothyroxine—CYP3A4—Triamcinolone—psoriasis	0.00646	0.0082	CbGbCtD
Levothyroxine—TTR—vertebral column—psoriasis	0.0056	0.256	CbGeAlD
Levothyroxine—CYP3A4—Betamethasone—psoriasis	0.00554	0.00704	CbGbCtD
Levothyroxine—CYP3A4—Prednisolone—psoriasis	0.00547	0.00694	CbGbCtD
Levothyroxine—ABCB1—Dexamethasone—psoriasis	0.00538	0.00683	CbGbCtD
Levothyroxine—CYP3A4—Hydrocortisone—psoriasis	0.00518	0.00658	CbGbCtD
Levothyroxine—CYP3A4—Prednisone—psoriasis	0.00516	0.00656	CbGbCtD
Levothyroxine—CYP3A4—Cyclosporine—psoriasis	0.00489	0.00621	CbGbCtD
Levothyroxine—ABCB1—Methotrexate—psoriasis	0.00432	0.00549	CbGbCtD
Levothyroxine—CYP3A4—Dexamethasone—psoriasis	0.00322	0.00409	CbGbCtD
Levothyroxine—SLC7A5—Mycophenolic acid—Mycophenolate mofetil—psoriasis	0.00141	0.224	CbGdCrCtD
Levothyroxine—CYP2C8—CYP2E1 reactions—CYP2S1—psoriasis	0.00126	0.0391	CbGpPWpGaD
Levothyroxine—SLC7A5—skin of body—psoriasis	0.00109	0.0499	CbGeAlD
Levothyroxine—THRA—tendon—psoriasis	0.00109	0.0498	CbGeAlD
Levothyroxine—THRB—tendon—psoriasis	0.00109	0.0498	CbGeAlD
Levothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.00109	0.0337	CbGpPWpGaD
Levothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—VDR—psoriasis	0.00109	0.0337	CbGpPWpGaD
Levothyroxine—SLC7A5—Isotretinoin—Acitretin—psoriasis	0.00107	0.17	CbGdCrCtD
Levothyroxine—SLC7A5—Alitretinoin—Acitretin—psoriasis	0.00107	0.17	CbGdCrCtD
Levothyroxine—SLC7A5—Tretinoin—Acitretin—psoriasis	0.00107	0.17	CbGdCrCtD
Levothyroxine—THRA—Endochondral Ossification—RUNX3—psoriasis	0.00104	0.0323	CbGpPWpGaD
Levothyroxine—SLC7A5—tendon—psoriasis	0.000832	0.038	CbGeAlD
Levothyroxine—THRA—Nuclear Receptors—VDR—psoriasis	0.000803	0.0248	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptors—VDR—psoriasis	0.000803	0.0248	CbGpPWpGaD
Levothyroxine—CYP2C8—Xenobiotics—CYP2S1—psoriasis	0.000784	0.0243	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.00078	0.0241	CbGpPWpGaD
Levothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.000758	0.0235	CbGpPWpGaD
Levothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—psoriasis	0.000758	0.0235	CbGpPWpGaD
Levothyroxine—THRA—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000635	0.0196	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptor transcription pathway—VDR—psoriasis	0.000635	0.0196	CbGpPWpGaD
Levothyroxine—SLC7A5—Cell surface interactions at the vascular wall—ITGAL—psoriasis	0.000577	0.0179	CbGpPWpGaD
Levothyroxine—THRA—Nuclear Receptors—PPARG—psoriasis	0.00056	0.0173	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptors—PPARG—psoriasis	0.00056	0.0173	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL22—psoriasis	0.000548	0.017	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—SERPINB8—psoriasis	0.000539	0.0167	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000511	0.0158	CbGpPWpGaD
Levothyroxine—SLCO1B1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000453	0.014	CbGpPWpGaD
Levothyroxine—THRA—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000442	0.0137	CbGpPWpGaD
Levothyroxine—THRB—Nuclear Receptor transcription pathway—PPARG—psoriasis	0.000442	0.0137	CbGpPWpGaD
Levothyroxine—TTR—Retinoid metabolism and transport—APOE—psoriasis	0.000431	0.0133	CbGpPWpGaD
Levothyroxine—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000421	0.013	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL13—psoriasis	0.000403	0.0125	CbGpPWpGaD
Levothyroxine—THRA—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000403	0.0125	CbGpPWpGaD
Levothyroxine—THRB—RXR and RAR heterodimerization with other nuclear receptor—TNF—psoriasis	0.000403	0.0125	CbGpPWpGaD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	0.000335	0.0104	CbGpPWpGaD
Levothyroxine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000325	0.0101	CbGpPWpGaD
Levothyroxine—CYP2C8—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000321	0.00994	CbGpPWpGaD
Levothyroxine—SLC7A5—Desoximetasone—Clobetasol propionate—psoriasis	0.000304	0.0482	CbGdCrCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	0.00029	0.00897	CbGpPWpGaD
Levothyroxine—SLCO4C1—SLC-mediated transmembrane transport—CP—psoriasis	0.000281	0.00871	CbGpPWpGaD
Levothyroxine—SLCO4A1—SLC-mediated transmembrane transport—CP—psoriasis	0.000281	0.00871	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—TARS—psoriasis	0.000281	0.00869	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—TARS—psoriasis	0.000281	0.00869	CbGpPWpGaD
Levothyroxine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000264	0.00817	CbGpPWpGaD
Levothyroxine—SLC7A5—SLC-mediated transmembrane transport—CP—psoriasis	0.000257	0.00796	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL10—psoriasis	0.000252	0.00781	CbGpPWpGaD
Levothyroxine—Rash—Acitretin—psoriasis	0.000252	0.00166	CcSEcCtD
Levothyroxine—Dermatitis—Acitretin—psoriasis	0.000252	0.00166	CcSEcCtD
Levothyroxine—Rash—Fluocinolone Acetonide—psoriasis	0.000251	0.00165	CcSEcCtD
Levothyroxine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000251	0.00165	CcSEcCtD
Levothyroxine—Headache—Acitretin—psoriasis	0.000251	0.00165	CcSEcCtD
Levothyroxine—Headache—Fluocinolone Acetonide—psoriasis	0.00025	0.00164	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Betamethasone—psoriasis	0.00025	0.00164	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Dexamethasone—psoriasis	0.00025	0.00164	CcSEcCtD
Levothyroxine—Tension—Mycophenolate mofetil—psoriasis	0.00025	0.00164	CcSEcCtD
Levothyroxine—Myocardial infarction—Betamethasone—psoriasis	0.000248	0.00163	CcSEcCtD
Levothyroxine—Myocardial infarction—Dexamethasone—psoriasis	0.000248	0.00163	CcSEcCtD
Levothyroxine—Body temperature increased—Hydroxyurea—psoriasis	0.000248	0.00163	CcSEcCtD
Levothyroxine—Nervousness—Mycophenolate mofetil—psoriasis	0.000247	0.00162	CcSEcCtD
Levothyroxine—Tremor—Cyclosporine—psoriasis	0.000244	0.00161	CcSEcCtD
Levothyroxine—SLC7A5—Desoximetasone—Fluocinonide—psoriasis	0.000244	0.0386	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Beclomethasone—psoriasis	0.000244	0.0386	CbGdCrCtD
Levothyroxine—Arrhythmia—Prednisolone—psoriasis	0.000243	0.0016	CcSEcCtD
Levothyroxine—Sweating increased—Prednisone—psoriasis	0.000241	0.00158	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Mycophenolic acid—psoriasis	0.00024	0.00158	CcSEcCtD
Levothyroxine—Agitation—Cyclosporine—psoriasis	0.00024	0.00157	CcSEcCtD
Levothyroxine—Tremor—Mycophenolate mofetil—psoriasis	0.000238	0.00157	CcSEcCtD
Levothyroxine—Angioedema—Cyclosporine—psoriasis	0.000238	0.00157	CcSEcCtD
Levothyroxine—Insomnia—Mycophenolic acid—psoriasis	0.000238	0.00156	CcSEcCtD
Levothyroxine—Arrhythmia—Hydrocortisone—psoriasis	0.000238	0.00156	CcSEcCtD
Levothyroxine—Nausea—Acitretin—psoriasis	0.000238	0.00156	CcSEcCtD
Levothyroxine—SLC7A5—Desoximetasone—Fluocinolone Acetonide—psoriasis	0.000237	0.0375	CbGdCrCtD
Levothyroxine—Nausea—Fluocinolone Acetonide—psoriasis	0.000237	0.00156	CcSEcCtD
Levothyroxine—SLCO1C1—SLC-mediated transmembrane transport—CP—psoriasis	0.000236	0.0073	CbGpPWpGaD
Levothyroxine—Dyspnoea—Mycophenolic acid—psoriasis	0.000234	0.00154	CcSEcCtD
Levothyroxine—Agitation—Mycophenolate mofetil—psoriasis	0.000234	0.00154	CcSEcCtD
Levothyroxine—Angioedema—Mycophenolate mofetil—psoriasis	0.000232	0.00153	CcSEcCtD
Levothyroxine—ALB—HDL-mediated lipid transport—APOE—psoriasis	0.000229	0.00709	CbGpPWpGaD
Levothyroxine—THRA—Endochondral Ossification—VEGFA—psoriasis	0.000229	0.00707	CbGpPWpGaD
Levothyroxine—Irritability—Methotrexate—psoriasis	0.000228	0.0015	CcSEcCtD
Levothyroxine—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000227	0.00702	CbGpPWpGaD
Levothyroxine—Fatigue—Mycophenolic acid—psoriasis	0.000227	0.00149	CcSEcCtD
Levothyroxine—Mood swings—Methotrexate—psoriasis	0.000227	0.00149	CcSEcCtD
Levothyroxine—Convulsion—Cyclosporine—psoriasis	0.000226	0.00148	CcSEcCtD
Levothyroxine—Asthenia—Hydroxyurea—psoriasis	0.000225	0.00148	CcSEcCtD
Levothyroxine—Palpitations—Mycophenolate mofetil—psoriasis	0.000225	0.00148	CcSEcCtD
Levothyroxine—Arrhythmia—Triamcinolone—psoriasis	0.000224	0.00147	CcSEcCtD
Levothyroxine—Weight decreased—Prednisone—psoriasis	0.000224	0.00147	CcSEcCtD
Levothyroxine—Arthralgia—Cyclosporine—psoriasis	0.000222	0.00146	CcSEcCtD
Levothyroxine—Anxiety—Cyclosporine—psoriasis	0.000221	0.00145	CcSEcCtD
Levothyroxine—TTR—Extracellular matrix organization—ITGAL—psoriasis	0.000221	0.00683	CbGpPWpGaD
Levothyroxine—Convulsion—Mycophenolate mofetil—psoriasis	0.00022	0.00145	CcSEcCtD
Levothyroxine—TTR—Diseases associated with visual transduction—APOE—psoriasis	0.00022	0.00681	CbGpPWpGaD
Levothyroxine—Acute coronary syndrome—Prednisone—psoriasis	0.000217	0.00143	CcSEcCtD
Levothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000217	0.00671	CbGpPWpGaD
Levothyroxine—Angioedema—Prednisolone—psoriasis	0.000217	0.00142	CcSEcCtD
Levothyroxine—Feeling abnormal—Mycophenolic acid—psoriasis	0.000217	0.00142	CcSEcCtD
Levothyroxine—Arthralgia—Mycophenolate mofetil—psoriasis	0.000216	0.00142	CcSEcCtD
Levothyroxine—Myocardial infarction—Prednisone—psoriasis	0.000216	0.00142	CcSEcCtD
Levothyroxine—Anxiety—Mycophenolate mofetil—psoriasis	0.000216	0.00142	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000215	0.00141	CcSEcCtD
Levothyroxine—Diarrhoea—Hydroxyurea—psoriasis	0.000215	0.00141	CcSEcCtD
Levothyroxine—Confusional state—Cyclosporine—psoriasis	0.000214	0.00141	CcSEcCtD
Levothyroxine—Angioedema—Hydrocortisone—psoriasis	0.000212	0.00139	CcSEcCtD
Levothyroxine—Confusional state—Mycophenolate mofetil—psoriasis	0.000209	0.00138	CcSEcCtD
Levothyroxine—Body temperature increased—Mycophenolic acid—psoriasis	0.000208	0.00137	CcSEcCtD
Levothyroxine—Abdominal pain—Mycophenolic acid—psoriasis	0.000208	0.00137	CcSEcCtD
Levothyroxine—Hyperhidrosis—Cyclosporine—psoriasis	0.000206	0.00135	CcSEcCtD
Levothyroxine—Convulsion—Prednisolone—psoriasis	0.000205	0.00135	CcSEcCtD
Levothyroxine—Shock—Mycophenolate mofetil—psoriasis	0.000204	0.00134	CcSEcCtD
Levothyroxine—Arrhythmia—Dexamethasone—psoriasis	0.000203	0.00134	CcSEcCtD
Levothyroxine—Arrhythmia—Betamethasone—psoriasis	0.000203	0.00134	CcSEcCtD
Levothyroxine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000203	0.00133	CcSEcCtD
Levothyroxine—Alopecia—Dexamethasone—psoriasis	0.000201	0.00132	CcSEcCtD
Levothyroxine—Alopecia—Betamethasone—psoriasis	0.000201	0.00132	CcSEcCtD
Levothyroxine—Convulsion—Hydrocortisone—psoriasis	0.000201	0.00132	CcSEcCtD
Levothyroxine—Hyperhidrosis—Mycophenolate mofetil—psoriasis	0.000201	0.00132	CcSEcCtD
Levothyroxine—Vomiting—Hydroxyurea—psoriasis	0.0002	0.00131	CcSEcCtD
Levothyroxine—Angioedema—Triamcinolone—psoriasis	0.000199	0.00131	CcSEcCtD
Levothyroxine—Rash—Hydroxyurea—psoriasis	0.000198	0.0013	CcSEcCtD
Levothyroxine—Dermatitis—Hydroxyurea—psoriasis	0.000198	0.0013	CcSEcCtD
Levothyroxine—Headache—Hydroxyurea—psoriasis	0.000197	0.00129	CcSEcCtD
Levothyroxine—Anxiety—Hydrocortisone—psoriasis	0.000197	0.00129	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000194	0.00127	CcSEcCtD
Levothyroxine—Insomnia—Cyclosporine—psoriasis	0.000192	0.00127	CcSEcCtD
Levothyroxine—Shock—Prednisolone—psoriasis	0.00019	0.00125	CcSEcCtD
Levothyroxine—Dyspnoea—Cyclosporine—psoriasis	0.00019	0.00125	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000189	0.00124	CcSEcCtD
Levothyroxine—Convulsion—Triamcinolone—psoriasis	0.000189	0.00124	CcSEcCtD
Levothyroxine—Tachycardia—Prednisolone—psoriasis	0.000189	0.00124	CcSEcCtD
Levothyroxine—Asthenia—Mycophenolic acid—psoriasis	0.000189	0.00124	CcSEcCtD
Levothyroxine—Insomnia—Mycophenolate mofetil—psoriasis	0.000188	0.00123	CcSEcCtD
Levothyroxine—Hyperhidrosis—Prednisolone—psoriasis	0.000187	0.00123	CcSEcCtD
Levothyroxine—Nausea—Hydroxyurea—psoriasis	0.000186	0.00123	CcSEcCtD
Levothyroxine—Pruritus—Mycophenolic acid—psoriasis	0.000186	0.00122	CcSEcCtD
Levothyroxine—Shock—Hydrocortisone—psoriasis	0.000186	0.00122	CcSEcCtD
Levothyroxine—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000185	0.00122	CcSEcCtD
Levothyroxine—Tachycardia—Hydrocortisone—psoriasis	0.000185	0.00121	CcSEcCtD
Levothyroxine—Flushing—Prednisone—psoriasis	0.000184	0.00121	CcSEcCtD
Levothyroxine—THRB—Generic Transcription Pathway—CARM1—psoriasis	0.000184	0.00568	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—CARM1—psoriasis	0.000184	0.00568	CbGpPWpGaD
Levothyroxine—Fatigue—Cyclosporine—psoriasis	0.000183	0.00121	CcSEcCtD
Levothyroxine—Hyperhidrosis—Hydrocortisone—psoriasis	0.000183	0.0012	CcSEcCtD
Levothyroxine—Angioedema—Betamethasone—psoriasis	0.000181	0.00119	CcSEcCtD
Levothyroxine—Angioedema—Dexamethasone—psoriasis	0.000181	0.00119	CcSEcCtD
Levothyroxine—Diarrhoea—Mycophenolic acid—psoriasis	0.00018	0.00118	CcSEcCtD
Levothyroxine—Arrhythmia—Prednisone—psoriasis	0.000177	0.00116	CcSEcCtD
Levothyroxine—Sweating—Methotrexate—psoriasis	0.000177	0.00116	CcSEcCtD
Levothyroxine—Feeling abnormal—Cyclosporine—psoriasis	0.000175	0.00115	CcSEcCtD
Levothyroxine—Shock—Triamcinolone—psoriasis	0.000175	0.00115	CcSEcCtD
Levothyroxine—Insomnia—Prednisolone—psoriasis	0.000175	0.00115	CcSEcCtD
Levothyroxine—Alopecia—Prednisone—psoriasis	0.000175	0.00115	CcSEcCtD
Levothyroxine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000175	0.00541	CbGpPWpGaD
Levothyroxine—Gastrointestinal pain—Cyclosporine—psoriasis	0.000174	0.00114	CcSEcCtD
Levothyroxine—Tachycardia—Triamcinolone—psoriasis	0.000174	0.00114	CcSEcCtD
Levothyroxine—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000172	0.00534	CbGpPWpGaD
Levothyroxine—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000172	0.00113	CcSEcCtD
Levothyroxine—Hyperhidrosis—Triamcinolone—psoriasis	0.000172	0.00113	CcSEcCtD
Levothyroxine—Convulsion—Betamethasone—psoriasis	0.000171	0.00113	CcSEcCtD
Levothyroxine—Convulsion—Dexamethasone—psoriasis	0.000171	0.00113	CcSEcCtD
Levothyroxine—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000171	0.00112	CcSEcCtD
Levothyroxine—Insomnia—Hydrocortisone—psoriasis	0.000171	0.00112	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.00017	0.00112	CcSEcCtD
Levothyroxine—Urticaria—Cyclosporine—psoriasis	0.000169	0.00111	CcSEcCtD
Levothyroxine—Abdominal pain—Cyclosporine—psoriasis	0.000168	0.00111	CcSEcCtD
Levothyroxine—Body temperature increased—Cyclosporine—psoriasis	0.000168	0.00111	CcSEcCtD
Levothyroxine—Anxiety—Dexamethasone—psoriasis	0.000168	0.0011	CcSEcCtD
Levothyroxine—Anxiety—Betamethasone—psoriasis	0.000168	0.0011	CcSEcCtD
Levothyroxine—Vomiting—Mycophenolic acid—psoriasis	0.000167	0.0011	CcSEcCtD
Levothyroxine—Rash—Mycophenolic acid—psoriasis	0.000166	0.00109	CcSEcCtD
Levothyroxine—Dermatitis—Mycophenolic acid—psoriasis	0.000166	0.00109	CcSEcCtD
Levothyroxine—Urticaria—Mycophenolate mofetil—psoriasis	0.000165	0.00108	CcSEcCtD
Levothyroxine—Headache—Mycophenolic acid—psoriasis	0.000165	0.00108	CcSEcCtD
Levothyroxine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000164	0.00108	CcSEcCtD
Levothyroxine—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000164	0.00108	CcSEcCtD
Levothyroxine—Fatigue—Hydrocortisone—psoriasis	0.000163	0.00107	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000162	0.00107	CcSEcCtD
Levothyroxine—Insomnia—Triamcinolone—psoriasis	0.000161	0.00106	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisolone—psoriasis	0.00016	0.00105	CcSEcCtD
Levothyroxine—Shock—Dexamethasone—psoriasis	0.000159	0.00104	CcSEcCtD
Levothyroxine—Shock—Betamethasone—psoriasis	0.000159	0.00104	CcSEcCtD
Levothyroxine—Dyspnoea—Triamcinolone—psoriasis	0.000159	0.00104	CcSEcCtD
Levothyroxine—Agitation—Prednisone—psoriasis	0.000158	0.00104	CcSEcCtD
Levothyroxine—Tachycardia—Dexamethasone—psoriasis	0.000158	0.00104	CcSEcCtD
Levothyroxine—Tachycardia—Betamethasone—psoriasis	0.000158	0.00104	CcSEcCtD
Levothyroxine—Angioedema—Prednisone—psoriasis	0.000157	0.00104	CcSEcCtD
Levothyroxine—SLC7A5—Hemostasis—ITGAL—psoriasis	0.000156	0.00484	CbGpPWpGaD
Levothyroxine—Nausea—Mycophenolic acid—psoriasis	0.000156	0.00103	CcSEcCtD
Levothyroxine—Hyperhidrosis—Betamethasone—psoriasis	0.000156	0.00103	CcSEcCtD
Levothyroxine—Hyperhidrosis—Dexamethasone—psoriasis	0.000156	0.00103	CcSEcCtD
Levothyroxine—Feeling abnormal—Hydrocortisone—psoriasis	0.000156	0.00102	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000155	0.00102	CcSEcCtD
Levothyroxine—Urticaria—Prednisolone—psoriasis	0.000154	0.00101	CcSEcCtD
Levothyroxine—Fatigue—Triamcinolone—psoriasis	0.000153	0.00101	CcSEcCtD
Levothyroxine—Asthenia—Cyclosporine—psoriasis	0.000153	0.001	CcSEcCtD
Levothyroxine—Pruritus—Cyclosporine—psoriasis	0.00015	0.00099	CcSEcCtD
Levothyroxine—Urticaria—Hydrocortisone—psoriasis	0.00015	0.000988	CcSEcCtD
Levothyroxine—Abdominal pain—Hydrocortisone—psoriasis	0.000149	0.000983	CcSEcCtD
Levothyroxine—Body temperature increased—Hydrocortisone—psoriasis	0.000149	0.000983	CcSEcCtD
Levothyroxine—Convulsion—Prednisone—psoriasis	0.000149	0.000982	CcSEcCtD
Levothyroxine—Asthenia—Mycophenolate mofetil—psoriasis	0.000149	0.000979	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000147	0.000968	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000147	0.000968	CcSEcCtD
Levothyroxine—Pruritus—Mycophenolate mofetil—psoriasis	0.000147	0.000965	CcSEcCtD
Levothyroxine—Arthralgia—Prednisone—psoriasis	0.000147	0.000965	CcSEcCtD
Levothyroxine—Feeling abnormal—Triamcinolone—psoriasis	0.000147	0.000965	CcSEcCtD
Levothyroxine—Anxiety—Prednisone—psoriasis	0.000146	0.000961	CcSEcCtD
Levothyroxine—Alopecia—Methotrexate—psoriasis	0.000146	0.000961	CcSEcCtD
Levothyroxine—Insomnia—Betamethasone—psoriasis	0.000146	0.000961	CcSEcCtD
Levothyroxine—Insomnia—Dexamethasone—psoriasis	0.000146	0.000961	CcSEcCtD
Levothyroxine—Diarrhoea—Cyclosporine—psoriasis	0.000146	0.000957	CcSEcCtD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—CP—psoriasis	0.000143	0.00442	CbGpPWpGaD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—CP—psoriasis	0.000143	0.00442	CbGpPWpGaD
Levothyroxine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000142	0.000934	CcSEcCtD
Levothyroxine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000142	0.00438	CbGpPWpGaD
Levothyroxine—Urticaria—Triamcinolone—psoriasis	0.000141	0.00093	CcSEcCtD
Levothyroxine—Body temperature increased—Triamcinolone—psoriasis	0.000141	0.000925	CcSEcCtD
Levothyroxine—CYP2C8—Biological oxidations—CYP2S1—psoriasis	0.00014	0.00434	CbGpPWpGaD
Levothyroxine—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.00014	0.00432	CbGpPWpGaD
Levothyroxine—Fatigue—Dexamethasone—psoriasis	0.000139	0.000916	CcSEcCtD
Levothyroxine—Fatigue—Betamethasone—psoriasis	0.000139	0.000916	CcSEcCtD
Levothyroxine—Shock—Prednisone—psoriasis	0.000138	0.00091	CcSEcCtD
Levothyroxine—CYP2C8—Metapathway biotransformation—CYP2S1—psoriasis	0.000138	0.00428	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—CXCL8—psoriasis	0.000138	0.00427	CbGpPWpGaD
Levothyroxine—Tachycardia—Prednisone—psoriasis	0.000137	0.000903	CcSEcCtD
Levothyroxine—SLCO4C1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000136	0.00422	CbGpPWpGaD
Levothyroxine—SLCO4A1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000136	0.00422	CbGpPWpGaD
Levothyroxine—Hyperhidrosis—Prednisone—psoriasis	0.000136	0.000894	CcSEcCtD
Levothyroxine—Asthenia—Hydrocortisone—psoriasis	0.000136	0.000892	CcSEcCtD
Levothyroxine—Vomiting—Cyclosporine—psoriasis	0.000135	0.000889	CcSEcCtD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000134	0.00416	CbGpPWpGaD
Levothyroxine—Rash—Cyclosporine—psoriasis	0.000134	0.000882	CcSEcCtD
Levothyroxine—Dermatitis—Cyclosporine—psoriasis	0.000134	0.000881	CcSEcCtD
Levothyroxine—Pruritus—Hydrocortisone—psoriasis	0.000134	0.000879	CcSEcCtD
Levothyroxine—SLCO1B3—SLC-mediated transmembrane transport—CP—psoriasis	0.000134	0.00413	CbGpPWpGaD
Levothyroxine—Headache—Cyclosporine—psoriasis	0.000133	0.000876	CcSEcCtD
Levothyroxine—Feeling abnormal—Dexamethasone—psoriasis	0.000133	0.000875	CcSEcCtD
Levothyroxine—Feeling abnormal—Betamethasone—psoriasis	0.000133	0.000875	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Betamethasone—psoriasis	0.000132	0.000868	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Dexamethasone—psoriasis	0.000132	0.000868	CcSEcCtD
Levothyroxine—Vomiting—Mycophenolate mofetil—psoriasis	0.000132	0.000868	CcSEcCtD
Levothyroxine—ALB—Lipoprotein metabolism—APOE—psoriasis	0.000132	0.00407	CbGpPWpGaD
Levothyroxine—Rash—Mycophenolate mofetil—psoriasis	0.000131	0.00086	CcSEcCtD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—CP—psoriasis	0.000131	0.00405	CbGpPWpGaD
Levothyroxine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000131	0.00086	CcSEcCtD
Levothyroxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.00013	0.00403	CbGpPWpGaD
Levothyroxine—Headache—Mycophenolate mofetil—psoriasis	0.00013	0.000855	CcSEcCtD
Levothyroxine—Diarrhoea—Hydrocortisone—psoriasis	0.000129	0.000851	CcSEcCtD
Levothyroxine—Urticaria—Dexamethasone—psoriasis	0.000128	0.000844	CcSEcCtD
Levothyroxine—Urticaria—Betamethasone—psoriasis	0.000128	0.000844	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—JUN—psoriasis	0.000128	0.00397	CbGpPWpGaD
Levothyroxine—Musculoskeletal discomfort—Prednisone—psoriasis	0.000128	0.000843	CcSEcCtD
Levothyroxine—Asthenia—Triamcinolone—psoriasis	0.000128	0.00084	CcSEcCtD
Levothyroxine—Body temperature increased—Betamethasone—psoriasis	0.000128	0.00084	CcSEcCtD
Levothyroxine—Abdominal pain—Dexamethasone—psoriasis	0.000128	0.00084	CcSEcCtD
Levothyroxine—Body temperature increased—Dexamethasone—psoriasis	0.000128	0.00084	CcSEcCtD
Levothyroxine—Abdominal pain—Betamethasone—psoriasis	0.000128	0.00084	CcSEcCtD
Levothyroxine—Insomnia—Prednisone—psoriasis	0.000127	0.000837	CcSEcCtD
Levothyroxine—Nausea—Cyclosporine—psoriasis	0.000126	0.000831	CcSEcCtD
Levothyroxine—Pruritus—Triamcinolone—psoriasis	0.000126	0.000828	CcSEcCtD
Levothyroxine—Convulsion—Methotrexate—psoriasis	0.000125	0.000821	CcSEcCtD
Levothyroxine—SLC7A5—Transmembrane transport of small molecules—CARM1—psoriasis	0.000125	0.00386	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—NFKB1—psoriasis	0.000123	0.00382	CbGpPWpGaD
Levothyroxine—Nausea—Mycophenolate mofetil—psoriasis	0.000123	0.00081	CcSEcCtD
Levothyroxine—Arthralgia—Methotrexate—psoriasis	0.000123	0.000806	CcSEcCtD
Levothyroxine—Rash—Prednisolone—psoriasis	0.000122	0.000803	CcSEcCtD
Levothyroxine—Dermatitis—Prednisolone—psoriasis	0.000122	0.000802	CcSEcCtD
Levothyroxine—Fatigue—Prednisone—psoriasis	0.000121	0.000797	CcSEcCtD
Levothyroxine—Headache—Prednisolone—psoriasis	0.000121	0.000797	CcSEcCtD
Levothyroxine—Vomiting—Hydrocortisone—psoriasis	0.00012	0.00079	CcSEcCtD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—CP—psoriasis	0.00012	0.00371	CbGpPWpGaD
Levothyroxine—SLC7A5—Desoximetasone—Hydrocortisone—psoriasis	0.00012	0.0189	CbGdCrCtD
Levothyroxine—Rash—Hydrocortisone—psoriasis	0.000119	0.000784	CcSEcCtD
Levothyroxine—Dermatitis—Hydrocortisone—psoriasis	0.000119	0.000783	CcSEcCtD
Levothyroxine—Confusional state—Methotrexate—psoriasis	0.000119	0.000779	CcSEcCtD
Levothyroxine—Headache—Hydrocortisone—psoriasis	0.000118	0.000779	CcSEcCtD
Levothyroxine—Feeling abnormal—Prednisone—psoriasis	0.000116	0.000762	CcSEcCtD
Levothyroxine—Asthenia—Dexamethasone—psoriasis	0.000116	0.000762	CcSEcCtD
Levothyroxine—Asthenia—Betamethasone—psoriasis	0.000116	0.000762	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Prednisone—psoriasis	0.000115	0.000756	CcSEcCtD
Levothyroxine—Nausea—Prednisolone—psoriasis	0.000115	0.000756	CcSEcCtD
Levothyroxine—SLCO1C1—Transmembrane transport of small molecules—CARM1—psoriasis	0.000114	0.00354	CbGpPWpGaD
Levothyroxine—Pruritus—Dexamethasone—psoriasis	0.000114	0.000751	CcSEcCtD
Levothyroxine—Pruritus—Betamethasone—psoriasis	0.000114	0.000751	CcSEcCtD
Levothyroxine—Hyperhidrosis—Methotrexate—psoriasis	0.000114	0.000747	CcSEcCtD
Levothyroxine—Vomiting—Triamcinolone—psoriasis	0.000113	0.000744	CcSEcCtD
Levothyroxine—Nausea—Hydrocortisone—psoriasis	0.000112	0.000738	CcSEcCtD
Levothyroxine—Rash—Triamcinolone—psoriasis	0.000112	0.000738	CcSEcCtD
Levothyroxine—Dermatitis—Triamcinolone—psoriasis	0.000112	0.000737	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—VEGFA—psoriasis	0.000112	0.00347	CbGpPWpGaD
Levothyroxine—Urticaria—Prednisone—psoriasis	0.000112	0.000735	CcSEcCtD
Levothyroxine—Headache—Triamcinolone—psoriasis	0.000112	0.000733	CcSEcCtD
Levothyroxine—Abdominal pain—Prednisone—psoriasis	0.000111	0.000731	CcSEcCtD
Levothyroxine—Body temperature increased—Prednisone—psoriasis	0.000111	0.000731	CcSEcCtD
Levothyroxine—SLC7A5—Desoximetasone—Dexamethasone—psoriasis	0.000111	0.0176	CbGdCrCtD
Levothyroxine—SLC7A5—Desoximetasone—Betamethasone—psoriasis	0.000111	0.0176	CbGdCrCtD
Levothyroxine—Diarrhoea—Dexamethasone—psoriasis	0.000111	0.000727	CcSEcCtD
Levothyroxine—Diarrhoea—Betamethasone—psoriasis	0.000111	0.000727	CcSEcCtD
Levothyroxine—THRA—Generic Transcription Pathway—VDR—psoriasis	0.00011	0.00339	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—VDR—psoriasis	0.00011	0.00339	CbGpPWpGaD
Levothyroxine—SLC7A5—Desoximetasone—Triamcinolone—psoriasis	0.000109	0.0172	CbGdCrCtD
Levothyroxine—ALB—Hemostasis—SERPINB8—psoriasis	0.000107	0.00332	CbGpPWpGaD
Levothyroxine—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000107	0.000704	CcSEcCtD
Levothyroxine—Insomnia—Methotrexate—psoriasis	0.000106	0.000699	CcSEcCtD
Levothyroxine—Nausea—Triamcinolone—psoriasis	0.000106	0.000695	CcSEcCtD
Levothyroxine—SLCO1A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000105	0.00325	CbGpPWpGaD
Levothyroxine—Dyspnoea—Methotrexate—psoriasis	0.000105	0.000689	CcSEcCtD
Levothyroxine—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000104	0.00321	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL13—psoriasis	0.000103	0.00319	CbGpPWpGaD
Levothyroxine—SLC7A5—Desoximetasone—Prednisone—psoriasis	0.000103	0.0163	CbGdCrCtD
Levothyroxine—Vomiting—Betamethasone—psoriasis	0.000103	0.000675	CcSEcCtD
Levothyroxine—Vomiting—Dexamethasone—psoriasis	0.000103	0.000675	CcSEcCtD
Levothyroxine—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—psoriasis	0.000102	0.00317	CbGpPWpGaD
Levothyroxine—Rash—Betamethasone—psoriasis	0.000102	0.00067	CcSEcCtD
Levothyroxine—Rash—Dexamethasone—psoriasis	0.000102	0.00067	CcSEcCtD
Levothyroxine—Dermatitis—Betamethasone—psoriasis	0.000102	0.000669	CcSEcCtD
Levothyroxine—Dermatitis—Dexamethasone—psoriasis	0.000102	0.000669	CcSEcCtD
Levothyroxine—Fatigue—Methotrexate—psoriasis	0.000101	0.000666	CcSEcCtD
Levothyroxine—Headache—Dexamethasone—psoriasis	0.000101	0.000665	CcSEcCtD
Levothyroxine—Headache—Betamethasone—psoriasis	0.000101	0.000665	CcSEcCtD
Levothyroxine—Asthenia—Prednisone—psoriasis	0.000101	0.000664	CcSEcCtD
Levothyroxine—SLC7A5—Desoximetasone—Prednisolone—psoriasis	0.000101	0.0159	CbGdCrCtD
Levothyroxine—Pruritus—Prednisone—psoriasis	9.95e-05	0.000654	CcSEcCtD
Levothyroxine—Feeling abnormal—Methotrexate—psoriasis	9.69e-05	0.000637	CcSEcCtD
Levothyroxine—Diarrhoea—Prednisone—psoriasis	9.62e-05	0.000633	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Methotrexate—psoriasis	9.61e-05	0.000632	CcSEcCtD
Levothyroxine—THRB—SIDS Susceptibility Pathways—TNF—psoriasis	9.6e-05	0.00297	CbGpPWpGaD
Levothyroxine—Nausea—Betamethasone—psoriasis	9.59e-05	0.000631	CcSEcCtD
Levothyroxine—Nausea—Dexamethasone—psoriasis	9.59e-05	0.000631	CcSEcCtD
Levothyroxine—ABCB1—Allograft Rejection—IL17A—psoriasis	9.5e-05	0.00294	CbGpPWpGaD
Levothyroxine—Urticaria—Methotrexate—psoriasis	9.34e-05	0.000614	CcSEcCtD
Levothyroxine—Abdominal pain—Methotrexate—psoriasis	9.29e-05	0.000611	CcSEcCtD
Levothyroxine—Body temperature increased—Methotrexate—psoriasis	9.29e-05	0.000611	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—HCAR2—psoriasis	9.27e-05	0.00287	CbGpPWpGaD
Levothyroxine—TTR—Extracellular matrix organization—ICAM1—psoriasis	9.12e-05	0.00282	CbGpPWpGaD
Levothyroxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.08e-05	0.00281	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—CAT—psoriasis	9.01e-05	0.00279	CbGpPWpGaD
Levothyroxine—SLCO1B1—SLC-mediated transmembrane transport—CP—psoriasis	8.97e-05	0.00278	CbGpPWpGaD
Levothyroxine—Vomiting—Prednisone—psoriasis	8.94e-05	0.000588	CcSEcCtD
Levothyroxine—Rash—Prednisone—psoriasis	8.87e-05	0.000583	CcSEcCtD
Levothyroxine—Dermatitis—Prednisone—psoriasis	8.86e-05	0.000583	CcSEcCtD
Levothyroxine—THRA—Gene Expression—CARM1—psoriasis	8.84e-05	0.00273	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—CARM1—psoriasis	8.84e-05	0.00273	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL12B—psoriasis	8.83e-05	0.00273	CbGpPWpGaD
Levothyroxine—Headache—Prednisone—psoriasis	8.81e-05	0.000579	CcSEcCtD
Levothyroxine—ALB—Vitamin B12 Metabolism—CRP—psoriasis	8.79e-05	0.00272	CbGpPWpGaD
Levothyroxine—ALB—Lipid and lipoprotein metabolism—APOE—psoriasis	8.74e-05	0.0027	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-E—psoriasis	8.62e-05	0.00267	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—APOE—psoriasis	8.6e-05	0.00266	CbGpPWpGaD
Levothyroxine—Asthenia—Methotrexate—psoriasis	8.43e-05	0.000555	CcSEcCtD
Levothyroxine—Nausea—Prednisone—psoriasis	8.35e-05	0.000549	CcSEcCtD
Levothyroxine—Pruritus—Methotrexate—psoriasis	8.32e-05	0.000547	CcSEcCtD
Levothyroxine—ALB—Folate Metabolism—IL4—psoriasis	8.27e-05	0.00256	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—ICAM1—psoriasis	8.08e-05	0.0025	CbGpPWpGaD
Levothyroxine—Diarrhoea—Methotrexate—psoriasis	8.04e-05	0.000529	CcSEcCtD
Levothyroxine—TTR—Signaling Pathways—TAGAP—psoriasis	8.04e-05	0.00249	CbGpPWpGaD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	8.02e-05	0.00248	CbGpPWpGaD
Levothyroxine—THRB—SIDS Susceptibility Pathways—IL6—psoriasis	7.75e-05	0.0024	CbGpPWpGaD
Levothyroxine—THRA—Generic Transcription Pathway—PPARG—psoriasis	7.64e-05	0.00236	CbGpPWpGaD
Levothyroxine—THRB—Generic Transcription Pathway—PPARG—psoriasis	7.64e-05	0.00236	CbGpPWpGaD
Levothyroxine—CYP3A4—Biological oxidations—CYP2S1—psoriasis	7.52e-05	0.00233	CbGpPWpGaD
Levothyroxine—Vomiting—Methotrexate—psoriasis	7.47e-05	0.000491	CcSEcCtD
Levothyroxine—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	7.42e-05	0.0023	CbGpPWpGaD
Levothyroxine—Rash—Methotrexate—psoriasis	7.41e-05	0.000487	CcSEcCtD
Levothyroxine—Dermatitis—Methotrexate—psoriasis	7.41e-05	0.000487	CcSEcCtD
Levothyroxine—Headache—Methotrexate—psoriasis	7.36e-05	0.000484	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism—NDUFA5—psoriasis	7.3e-05	0.00226	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—CAT—psoriasis	7.16e-05	0.00221	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—CRP—psoriasis	7.15e-05	0.00221	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	7.13e-05	0.00221	CbGpPWpGaD
Levothyroxine—Nausea—Methotrexate—psoriasis	6.98e-05	0.000459	CcSEcCtD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.81e-05	0.00211	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—CP—psoriasis	6.79e-05	0.0021	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—ICAM1—psoriasis	6.57e-05	0.00203	CbGpPWpGaD
Levothyroxine—CYP3A4—Tryptophan metabolism—CAT—psoriasis	6.49e-05	0.00201	CbGpPWpGaD
Levothyroxine—SLCO1B3—Transmembrane transport of small molecules—CARM1—psoriasis	6.47e-05	0.002	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL10—psoriasis	6.45e-05	0.002	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—NOS2—psoriasis	6.42e-05	0.00199	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IL4—psoriasis	6.28e-05	0.00194	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CYP2S1—psoriasis	6.21e-05	0.00192	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IFNG—psoriasis	6.15e-05	0.0019	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.14e-05	0.0019	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.13e-05	0.0019	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—NDUFA5—psoriasis	5.74e-05	0.00178	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	5.71e-05	0.00177	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-A—psoriasis	5.69e-05	0.00176	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—CRP—psoriasis	5.68e-05	0.00176	CbGpPWpGaD
Levothyroxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	5.59e-05	0.00173	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	5.35e-05	0.00166	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	5.33e-05	0.00165	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—VDR—psoriasis	5.28e-05	0.00163	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—VDR—psoriasis	5.28e-05	0.00163	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—ICAM1—psoriasis	5.22e-05	0.00162	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.2e-05	0.00161	CbGpPWpGaD
Levothyroxine—ALB—SLC-mediated transmembrane transport—CP—psoriasis	5.13e-05	0.00159	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—NFKB1—psoriasis	5.12e-05	0.00158	CbGpPWpGaD
Levothyroxine—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.09e-05	0.00157	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IFNG—psoriasis	5e-05	0.00155	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—NDUFA5—psoriasis	4.91e-05	0.00152	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CYP2S1—psoriasis	4.88e-05	0.00151	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCL20—psoriasis	4.82e-05	0.00149	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	4.57e-05	0.00142	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—CP—psoriasis	4.56e-05	0.00141	CbGpPWpGaD
Levothyroxine—SLCO1B1—Transmembrane transport of small molecules—CARM1—psoriasis	4.35e-05	0.00135	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CYP2S1—psoriasis	4.17e-05	0.00129	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—NFKB1—psoriasis	4.16e-05	0.00129	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—TNF—psoriasis	3.98e-05	0.00123	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IFNG—psoriasis	3.97e-05	0.00123	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—IFNG—psoriasis	3.8e-05	0.00117	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	3.79e-05	0.00117	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—VEGFA—psoriasis	3.72e-05	0.00115	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—PPARG—psoriasis	3.68e-05	0.00114	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—PPARG—psoriasis	3.68e-05	0.00114	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—CXCL8—psoriasis	3.53e-05	0.00109	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.31e-05	0.00102	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—NFKB1—psoriasis	3.31e-05	0.00102	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.25e-05	0.00101	CbGpPWpGaD
Levothyroxine—ALB—Platelet degranulation—VEGFA—psoriasis	3.24e-05	0.001	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TNF—psoriasis	3.24e-05	0.001	CbGpPWpGaD
Levothyroxine—ALB—Vitamin B12 Metabolism—IL6—psoriasis	3.21e-05	0.000994	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—ITGAL—psoriasis	3.12e-05	0.000964	CbGpPWpGaD
Levothyroxine—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—psoriasis	3.09e-05	0.000955	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CARM1—psoriasis	3.03e-05	0.000938	CbGpPWpGaD
Levothyroxine—TTR—Disease—HLA-A—psoriasis	2.99e-05	0.000926	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.91e-05	0.000899	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—VEGFA—psoriasis	2.87e-05	0.000887	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—TP53—psoriasis	2.85e-05	0.000883	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.83e-05	0.000877	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—NDUFA5—psoriasis	2.82e-05	0.000872	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—TP53—psoriasis	2.81e-05	0.000869	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—NDUFA5—psoriasis	2.8e-05	0.000867	CbGpPWpGaD
Levothyroxine—TTR—Disease—APOE—psoriasis	2.79e-05	0.000865	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SOCS1—psoriasis	2.65e-05	0.000821	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.63e-05	0.000813	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.61e-05	0.000809	CbGpPWpGaD
Levothyroxine—ALB—Folate Metabolism—IL6—psoriasis	2.61e-05	0.000808	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—CP—psoriasis	2.6e-05	0.000806	CbGpPWpGaD
Levothyroxine—TTR—Disease—NOS2—psoriasis	2.6e-05	0.000806	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—TNF—psoriasis	2.57e-05	0.000796	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.56e-05	0.000791	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—CARM1—psoriasis	2.48e-05	0.000769	CbGpPWpGaD
Levothyroxine—ABCB1—Allograft Rejection—TNF—psoriasis	2.46e-05	0.00076	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—NDUFA5—psoriasis	2.46e-05	0.00076	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.44e-05	0.000756	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CYP2S1—psoriasis	2.4e-05	0.000742	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CYP2S1—psoriasis	2.38e-05	0.000738	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CARM1—psoriasis	2.38e-05	0.000737	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.28e-05	0.000706	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.23e-05	0.000689	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.19e-05	0.000676	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.18e-05	0.000674	CbGpPWpGaD
Levothyroxine—TTR—Disease—TYK2—psoriasis	2.13e-05	0.00066	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CYP2S1—psoriasis	2.09e-05	0.000646	CbGpPWpGaD
Levothyroxine—ALB—Selenium Micronutrient Network—IL6—psoriasis	2.08e-05	0.000642	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CARM1—psoriasis	2.04e-05	0.00063	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—APOE—psoriasis	1.96e-05	0.000606	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—LEP—psoriasis	1.96e-05	0.000606	CbGpPWpGaD
Levothyroxine—TTR—Disease—CD4—psoriasis	1.93e-05	0.000597	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.9e-05	0.000589	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CAT—psoriasis	1.86e-05	0.000577	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NFKBIA—psoriasis	1.82e-05	0.000564	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.62e-05	0.000501	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.56e-05	0.000482	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—NDUFA5—psoriasis	1.51e-05	0.000468	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TYK2—psoriasis	1.49e-05	0.000462	CbGpPWpGaD
Levothyroxine—TTR—Disease—STAT3—psoriasis	1.49e-05	0.000462	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CAT—psoriasis	1.47e-05	0.000453	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—APOE—psoriasis	1.45e-05	0.000448	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—psoriasis	1.44e-05	0.000445	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.41e-05	0.000438	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—psoriasis	1.3e-05	0.000402	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CYP2S1—psoriasis	1.29e-05	0.000398	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NOS2—psoriasis	1.28e-05	0.000396	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—psoriasis	1.26e-05	0.000391	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.26e-05	0.000389	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CAT—psoriasis	1.25e-05	0.000388	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.25e-05	0.000387	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.21e-05	0.000375	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—JUN—psoriasis	1.21e-05	0.000374	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CARM1—psoriasis	1.17e-05	0.000362	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CARM1—psoriasis	1.16e-05	0.00036	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NFKB1—psoriasis	1.16e-05	0.00036	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APOE—psoriasis	1.14e-05	0.000352	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.09e-05	0.000339	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.09e-05	0.000337	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.07e-05	0.000331	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—psoriasis	1.06e-05	0.000327	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—psoriasis	1.05e-05	0.000324	CbGpPWpGaD
Levothyroxine—TTR—Disease—IL6—psoriasis	1.04e-05	0.000323	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CARM1—psoriasis	1.02e-05	0.000316	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—psoriasis	9.92e-06	0.000307	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOE—psoriasis	9.74e-06	0.000301	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—psoriasis	8.48e-06	0.000262	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—psoriasis	7.98e-06	0.000247	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—psoriasis	7.4e-06	0.000229	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—IL6—psoriasis	7.3e-06	0.000226	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CAT—psoriasis	7.2e-06	0.000223	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CAT—psoriasis	7.16e-06	0.000222	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CARM1—psoriasis	6.28e-06	0.000194	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CAT—psoriasis	6.27e-06	0.000194	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—psoriasis	5.59e-06	0.000173	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOE—psoriasis	5.59e-06	0.000173	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOE—psoriasis	5.56e-06	0.000172	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOE—psoriasis	4.87e-06	0.000151	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—psoriasis	4.87e-06	0.000151	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—psoriasis	4.84e-06	0.00015	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—psoriasis	4.25e-06	0.000131	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CAT—psoriasis	3.86e-06	0.00012	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOE—psoriasis	3e-06	9.29e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—psoriasis	2.62e-06	8.09e-05	CbGpPWpGaD
